These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 8089930

  • 1. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J, Takahashi T, Agata M, Toyofuku H, Sasada N.
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [Abstract] [Full Text] [Related]

  • 2. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

  • 3. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Sep; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 4. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 5. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
    Perez V, Unzeta M.
    Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 7. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 8. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 9. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB, Gross A, Finberg JP.
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Jan; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 11. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N.
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [Abstract] [Full Text] [Related]

  • 12. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

  • 13. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S, Zheng H, Fridkin M, Youdim MB.
    J Neurochem; 2005 Oct 29; 95(1):79-88. PubMed ID: 16181414
    [Abstract] [Full Text] [Related]

  • 14. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB, Tipton KF.
    Parkinsonism Relat Disord; 2002 Mar 29; 8(4):247-53. PubMed ID: 12039419
    [Abstract] [Full Text] [Related]

  • 15. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y, Mash D, Zhang SH, Stein I.
    Mol Pharmacol; 1991 Mar 29; 39(3):385-93. PubMed ID: 1848660
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 29; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1985 Mar 29; 232(3):696-701. PubMed ID: 3871853
    [Abstract] [Full Text] [Related]

  • 18. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA, Voronina TA, Aksenova LN, Buneeva OA, Medvedev AE.
    Eksp Klin Farmakol; 2003 Mar 29; 66(5):3-5. PubMed ID: 14650204
    [Abstract] [Full Text] [Related]

  • 19. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT, Irwin I, Delanney LE, Langston JW.
    J Pharmacol Exp Ther; 1995 May 29; 273(2):716-20. PubMed ID: 7752075
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
    Wu WR, Zhu XZ, Guan HJ, Wang RG, Ji XQ.
    Zhongguo Yao Li Xue Bao; 1999 Feb 29; 20(2):146-50. PubMed ID: 10437162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.